Related Experiment Video
Updated: May 8, 2026
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Size-stable solid lipid nanoparticles loaded with Gd-DOTA for magnetic resonance imaging
Erica Andreozzi1, Peter Wang, Anthony Valenzuela
1Department of Biomedical Engineering, University of California Davis , Davis, California 95616, United States.
Bioconjugate Chemistry
|September 6, 2013
Summary
Solid lipid nanoparticles (SLNs) offer stable drug delivery and imaging capabilities. Researchers developed gadolinium-loaded SLNs for enhanced T1-weighted MRI contrast, showing improved performance over traditional liposomes.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Materials Science
Background:
- Solid lipid nanoparticles (SLNs) are emerging as safe and effective drug delivery systems.
- SLNs provide drug protection and controlled release, with potential for targeted delivery and multimodal imaging.
- Gadolinium (Gd)-based contrast agents are crucial for Magnetic Resonance Imaging (MRI).
Purpose of the Study:
- To synthesize and characterize SLNs loaded with gadolinium (1,4,7,10-tetraazacyclododecane)-1,4,7,10-tetraacetate (Gd-DOTA).
- To develop novel, stable T1-weighted (T1w) MRI contrast agents using Gd-DOTA-loaded SLNs.
- To evaluate the performance of these SLNs as MRI contrast agents, comparing them to existing technologies.
Main Methods:
- Systematic optimization of SLN synthesis components, focusing on surfactant (Span 80) concentration.
- Characterization of SLN properties including Gd-DOTA incorporation, size distribution, and stability.
- Measurement of longitudinal relaxivity (r1) of encapsulated Gd-DOTA at physiological conditions.
- In vivo evaluation of Gd-loaded SLNs using T1w MRI at 7T.
Main Results:
- Optimized SLN synthesis increased Gd-DOTA incorporation and longitudinal relaxivity (r1).
- Synthesized SLNs were highly monodisperse (∼150 nm) and demonstrated stable Gd-DOTA loading and size distribution.
- Gd-DOTA's r1 was well-preserved after encapsulation in SLNs, outperforming liposomes.
- Gd-loaded SLNs significantly enhanced in vivo contrast in T1w MRI.
Conclusions:
- Gd-DOTA-loaded SLNs represent a new class of stable and effective T1w MRI contrast agents.
- Optimized SLN formulation enhances Gd-DOTA loading and relaxivity, offering advantages over liposomes.
- These SLNs show potential for multimodal imaging applications by accommodating various cargo types.
